Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies

BACKGROUND: Bloodborne pathogens pose a major safety risk in transfusion medicine. To mitigate the risk of bacterial contamination in platelet units, FDA issues updated guidance materials on various bacterial risk control strategies (BRCS). This analysis presents results of a budget impact model upd...

Descripción completa

Detalles Bibliográficos
Autores principales: Prioli, Katherine M., Abersone, Ilze, Kopko, Patricia M., Herman, Jay H., Custer, Brian, Pizzi, Laura T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Donor Infectious Disease Testing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303536/
https://www.ncbi.nlm.nih.gov/pubmed/34997763
http://dx.doi.org/10.1111/trf.16778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303536/
https://www.ncbi.nlm.nih.gov/pubmed/34997763
http://dx.doi.org/10.1111/trf.16778

Ejemplares similares